|
US382425A
(en)
|
|
1888-05-08 |
|
Brandt |
|
US2909462A
(en)
|
1955-12-08 |
1959-10-20 |
Bristol Myers Co |
Acrylic acid polymer laxative compositions
|
|
US4769331A
(en)
|
1981-09-16 |
1988-09-06 |
University Patents, Inc. |
Recombinant methods and materials
|
|
US5364773A
(en)
|
1991-03-07 |
1994-11-15 |
Virogenetics Corporation |
Genetically engineered vaccine strain
|
|
US5338683A
(en)
|
1981-12-24 |
1994-08-16 |
Health Research Incorporated |
Vaccinia virus containing DNA sequences encoding herpesvirus glycoproteins
|
|
US5505941A
(en)
|
1981-12-24 |
1996-04-09 |
Health Research, Inc. |
Recombinant avipox virus and method to induce an immune response
|
|
US5833975A
(en)
|
1989-03-08 |
1998-11-10 |
Virogenetics Corporation |
Canarypox virus expressing cytokine and/or tumor-associated antigen DNA sequence
|
|
US5174993A
(en)
|
1981-12-24 |
1992-12-29 |
Health Research Inc. |
Recombinant avipox virus and immunological use thereof
|
|
US4603112A
(en)
|
1981-12-24 |
1986-07-29 |
Health Research, Incorporated |
Modified vaccinia virus
|
|
US4769330A
(en)
|
1981-12-24 |
1988-09-06 |
Health Research, Incorporated |
Modified vaccinia virus and methods for making and using the same
|
|
US4722848A
(en)
|
1982-12-08 |
1988-02-02 |
Health Research, Incorporated |
Method for immunizing animals with synthetically modified vaccinia virus
|
|
US4745051A
(en)
|
1983-05-27 |
1988-05-17 |
The Texas A&M University System |
Method for producing a recombinant baculovirus expression vector
|
|
US4552758A
(en)
|
1983-12-20 |
1985-11-12 |
St. Jude Children's Research Hospital |
Human use of avian-human reassortants as vaccines for influenza A virus
|
|
US4945050A
(en)
|
1984-11-13 |
1990-07-31 |
Cornell Research Foundation, Inc. |
Method for transporting substances into living cells and tissues and apparatus therefor
|
|
IE872748L
(en)
|
1986-10-16 |
1988-04-16 |
Arjomari Europ |
Polypeptides derived from the evvelope gene of human¹immunodeficiency virus in recombinant baculovirus infected¹insect cells
|
|
US5811128A
(en)
|
1986-10-24 |
1998-09-22 |
Southern Research Institute |
Method for oral or rectal delivery of microencapsulated vaccines and compositions therefor
|
|
US5075109A
(en)
|
1986-10-24 |
1991-12-24 |
Southern Research Institute |
Method of potentiating an immune response
|
|
GB8717430D0
(en)
|
1987-07-23 |
1987-08-26 |
Celltech Ltd |
Recombinant dna product
|
|
WO1990001543A1
(fr)
|
1988-07-29 |
1990-02-22 |
Intracel Corporation |
Procede d'expression genetique de proteines heterologues par des cellules transfectees in vivo
|
|
CA2003300A1
(en)
|
1988-11-21 |
1990-05-21 |
Franklin Volvovitz |
Skin test and test kit for aids
|
|
CA2357538A1
(en)
|
1989-03-21 |
1990-10-04 |
Wisconsin Alumni Research Foundation |
Expression of exogenous polynucleotide sequences in a vertebrate
|
|
US5703055A
(en)
|
1989-03-21 |
1997-12-30 |
Wisconsin Alumni Research Foundation |
Generation of antibodies through lipid mediated DNA delivery
|
|
US5552143A
(en)
|
1989-03-24 |
1996-09-03 |
The Wistar Institute Of Anatomy & Biology |
Recombinant cytomegalovirus vaccine
|
|
US5591439A
(en)
|
1989-03-24 |
1997-01-07 |
The Wistar Institute Of Anatomy And Biology |
Recombinant cytomegalovirus vaccine
|
|
US5690938A
(en)
|
1989-07-07 |
1997-11-25 |
Oravax, Inc. |
Oral immunization with multiple particulate antigen delivery system
|
|
US5436146A
(en)
|
1989-09-07 |
1995-07-25 |
The Trustees Of Princeton University |
Helper-free stocks of recombinant adeno-associated virus vectors
|
|
GB9001766D0
(en)
|
1990-01-25 |
1990-03-28 |
Univ Court Of The University O |
Vaccines
|
|
CA2080477A1
(en)
|
1990-04-24 |
1991-10-25 |
Flustat Pty. Ltd. |
Oral vaccine comprising antigen surface-associated with red blood cells
|
|
ATE247163T1
(de)
|
1991-03-07 |
2003-08-15 |
Virogenetics Corp |
Gentechnologisch hergestellter stamm für impfstoffe
|
|
US5997878A
(en)
|
1991-03-07 |
1999-12-07 |
Connaught Laboratories |
Recombinant poxvirus-cytomegalovirus, compositions and uses
|
|
EP0561034B1
(en)
|
1991-08-26 |
1999-06-09 |
IMMUNO Aktiengesellschaft |
Direct molecular cloning of a modified chordopox virus genome
|
|
US5643578A
(en)
|
1992-03-23 |
1997-07-01 |
University Of Massachusetts Medical Center |
Immunization by inoculation of DNA transcription unit
|
|
US5807722A
(en)
|
1992-10-30 |
1998-09-15 |
Bioengineering Resources, Inc. |
Biological production of acetic acid from waste gases with Clostridium ljungdahlii
|
|
US5846945A
(en)
|
1993-02-16 |
1998-12-08 |
Onyx Pharmaceuticals, Inc. |
Cytopathic viruses for therapy and prophylaxis of neoplasia
|
|
IL108915A0
(en)
|
1993-03-18 |
1994-06-24 |
Merck & Co Inc |
Polynucleotide vaccine against influenza virus
|
|
FR2711670B1
(fr)
|
1993-10-22 |
1996-01-12 |
Pasteur Institut |
Vecteur nucléotidique, composition le contenant et vaccin pour l'immunisation à l'encontre d'une hépatite.
|
|
EP0740704A1
(en)
|
1994-01-27 |
1996-11-06 |
University Of Massachusetts Medical Center |
Immunization by inoculation of dna transcription unit
|
|
JP3911010B2
(ja)
|
1994-04-29 |
2007-05-09 |
イムノ・アクテイエンゲゼルシヤフト |
必須領域に外来ポリヌクレオチドを有する組換えポックスウイルス
|
|
EP0871755A1
(en)
|
1995-03-23 |
1998-10-21 |
Cantab Pharmaceuticals Research Limited |
Vectors for gene delivery
|
|
WO1998000166A1
(en)
|
1996-07-03 |
1998-01-08 |
Merial, Inc. |
Recombinant canine adenovirus (cav) containing exogenous dna
|
|
US6183752B1
(en)
|
1997-02-05 |
2001-02-06 |
Pasteur Merieux Serums Et Vaccins |
Restenosis/atherosclerosis diagnosis, prophylaxis and therapy
|
|
US6204281B1
(en)
|
1998-07-10 |
2001-03-20 |
Novartis Ag |
Method of treatment and pharmaceutical composition
|
|
AU2001259211B2
(en)
|
2000-04-28 |
2006-07-13 |
St. Jude Children's Research Hospital |
DNA transfection system for the generation of infectious influenza virus
|
|
WO2002003872A2
(en)
|
2000-07-11 |
2002-01-17 |
Johns Hopkins University |
Application of photochemotherapy for the treatment of cardiac arrhythmias
|
|
WO2002062381A1
(en)
|
2001-02-05 |
2002-08-15 |
Hisamitsu Pharmaceutical Co., Inc. |
Baculovirus vector vaccine
|
|
US20040219208A1
(en)
|
2001-08-03 |
2004-11-04 |
Ryu Kawamura |
Sustained-release medicines
|
|
US20040146533A1
(en)
*
|
2002-08-27 |
2004-07-29 |
Miller Timothy J. |
Use of escherichia coli heat labile toxin as an adjuvant in birds and poultry
|
|
WO2005018539A2
(en)
|
2003-06-16 |
2005-03-03 |
Medimmune Vaccines, Inc. |
Influenza hemagglutinin and neuraminidase variants
|
|
US8080255B2
(en)
|
2003-07-11 |
2011-12-20 |
Novavax Inc. |
Functional influenza virus like particles (VLPs)
|
|
EP1722815A1
(en)
|
2004-03-09 |
2006-11-22 |
Chiron Corporation |
Influenza virus vaccines
|
|
ES2393492T3
(es)
|
2004-05-25 |
2012-12-21 |
Medimmune, Llc |
Variantes de hemaglutinina y neuraminidasa de influenza
|
|
CN1748795A
(zh)
|
2004-09-17 |
2006-03-22 |
金宁一 |
多价禽流感重组活载体疫苗
|
|
BRPI0609362A2
(pt)
|
2005-04-11 |
2010-03-30 |
Us Gov Health & Human Serv |
vetor de adenovìrus recombinante, adenovìrus recombinante, composição imunogênica e método para a produção da referida composição imunogênica
|
|
US7871626B2
(en)
|
2005-08-04 |
2011-01-18 |
St. Jude Children's Research Hospital |
Modified influenza virus for monitoring and improving vaccine efficiency
|
|
RU2483751C2
(ru)
|
2005-10-18 |
2013-06-10 |
Новавакс, Инк. |
ФУНКЦИОНАЛЬНЫЕ ВИРУСОПОДОБНЫЕ ЧАСТИЦЫ ГРИППА (VLPs)
|
|
CN101300023A
(zh)
*
|
2005-10-28 |
2008-11-05 |
贝林格尔·英格海姆维特梅迪卡有限公司 |
用于治疗/预防流感病原体在物种间传播的疫苗的用途
|
|
US20100150941A1
(en)
*
|
2006-09-13 |
2010-06-17 |
Dso National Laboratories |
Hemagglutinin antibody and uses thereof
|
|
AR063427A1
(es)
*
|
2006-10-27 |
2009-01-28 |
Boehringer Ingelheim Vetmed |
Proteinas h5, moleculas de acido nucleico y vectores que las codifican y su uso medicinal
|
|
US8202967B2
(en)
|
2006-10-27 |
2012-06-19 |
Boehringer Ingelheim Vetmedica, Inc. |
H5 proteins, nucleic acid molecules and vectors encoding for those, and their medicinal use
|
|
US7981428B2
(en)
|
2008-01-23 |
2011-07-19 |
Academia Sinica |
Flu vaccines and methods of use thereof
|
|
SG184804A1
(en)
|
2010-04-30 |
2012-11-29 |
Temasek Life Sciences Lab Ltd |
Universal vaccine against h5n1 lineages
|
|
AR088028A1
(es)
|
2011-08-15 |
2014-05-07 |
Boehringer Ingelheim Vetmed |
Proteinas h5, de h5n1 para un uso medicinal
|
|
EP2958586B1
(en)
|
2013-02-21 |
2018-09-05 |
Boehringer Ingelheim Vetmedica GmbH |
H5 proteins of h5n1 influenza virus for use as a medicament
|